Congrats to our resident company Optimeos Life Sciences!
Posted Wednesday, February 12, 2020
It’s all in the delivery—nanoparticle platform could transform medical treatments
“Optimeos Life Sciences, a startup founded by two Princeton University faculty members, has reached agreements with six pharmaceutical companies to develop therapeutics using a Princeton-developed drug delivery technology. The partnerships have the potential to improve the effectiveness of medications for the treatment of diseases, ranging from cancer to diabetes.”